Introduction Atopic dermatitis (AD) is a chronic and recurrent inflammatory skin disease characterized by refractory eczematous lesions and intense pruritus. Factors contributing to the refractory nature and recurrence of AD, especially during remission, include increased cutaneous permeability and deficient water-holding functions in the stratum corneum (SC), even in nonlesional skin [1].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Yusuke Ohno
Acid ceramidase ASAH1 is a key regulator of epidermal ceramide levels and composition
Keywords ceramidase ceramide enzyme kinetics epidermis gene knockout lipid liposome mass spectrometry (MS) metabolism sphingolipid Abbreviations—The abbreviations used are A (α-hydroxy fatty acid) CDS (coding sequence) d (deuterium) dS (dihydrosphingosine) EO (esterified ω-hydroxy fatty acid) FA (fatty acid) H (6-hydroxysphingosine) HEK (human embryonic kidney) KO (knockout) MRM (multiple reaction monitoring) MS/MS (tandem MS) N (non-hydroxy fatty acid) O (ω-hydroxy FA) P (phytosphingosine)...
Novel mechanisms by which benralizumab suppresses IgE expression in human B cells in humanized mice
DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.
Determining the structure of protein-bound ceramides, essential lipids for skin barrier function
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Skin permeability barrier formation by the ichthyosis-causative gene FATP4 through formation of the barrier lipid ω-O-acylceramide
A study finds a shift in onset of El Niño events from eastern to western Pacific and increased frequency of extreme El Niño events since the late 1970s.
Structure-inspired design of a sphingolipid mimic sphingosine-1-phosphate receptor agonist from a naturally occurring sphingomyelin synthase inhibitor
Ginkgolic acid obtained as sphingomyelin synthase inhibitor from plant extract library inspired the concept of sphingolipid mimic. Ginkgolic acid derived N-acyl anilines and ginkgolic acid 2-phosphate (GA2P) mimics ceramide and sphingosine 1-phosphate (S1P) respectively in structure and function. GA2P induced phosphorylation of ERK and internalization of S1P receptor 1 (S1P1), indicated potent agonist activity.
The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways
Differences among fatty acids (FAs) in chain length and number of double bonds create lipid diversity. FA elongation proceeds via a four-step reaction cycle, in which the 3-hydroxyacyl-CoA dehydratases (HACDs) HACD1–4 catalyze the third step. However, the contribution of each HACD to 3-hydroxyacyl-CoA dehydratase activity in certain tissues or in different FA elongation pathways remains unclear. HACD1 is specifically expressed in muscles and is a myopathy-causative gene.
The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways
Differences among fatty acids (FAs) in chain length and number of double bonds create lipid diversity. FA elongation proceeds via a four-step reaction cycle, in which the 3-hydroxyacyl-CoA dehydratases HACD1-4 catalyze the third step. However, the contribution of each HACD to 3-hydroxyacyl-CoA dehydratase activity in certain tissues or in different FA elongation pathways remains unclear. HACD1 is specifically expressed in muscles and is a myopathy-causative gene.
PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide
To identify the acyltransferase or transacylase involved in acylceramide production, a proper assay system that can detect its activity or product is necessary. However, the prior lack of such assay systems meant there was no way of identifying the responsible acyltransferase/transacylase for a long time. Cell-based assays had been unsuccessful, since most mammalian cells cannot produce ULC ?-hydroxyceramides, the precursors of acylceramides.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Yusuke
Contact Yusuke, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack